Escalon Medical Corp.
ESMC · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $0 |
| Revenue | $3 | $0 | $0 | $0 |
| % Growth | 103,995.9% | -26% | 7.9% | – |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 41.9% | 43.7% | 46.1% | 48.9% |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | -8.5% | -14.1% | 8.2% | 8.1% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -9% | -14.8% | 7.8% | 7.6% |
| EPS Diluted | -0.03 | -0.028 | 0.018 | 0.02 |
| % Growth | -8.3% | -251.4% | -8.5% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |